Novartis in Society Integrated Report 2022

Novartis in Society
Integrated Report
2022

Novartis is a focused medicines company.
Our purpose is to reimagine medicine to improve and extend people's lives.

Who we are

Novartis is one of the world’s leading medicines companies. We use innovative science and technology to address some of society’s most challenging healthcare issues.

Learn more

Learn more

How we create value

Through our core business, we improve and extend the lives of millions of people around the world, while creating value for our employees, shareholders and the communities in which we operate.

Innovation

Operations and supply chain

Access for patients

Social, financial & economic value

Innovation

Operations and supply chain

Access for patients

Social, financial & economic value

Learn more

CEO’s letter

As we look to the future as a focused medicines company, our dedication to innovation and excellence will drive us forward.

Vas Narasimhan
Chief Executive Officer

Read the CEO's letter

Our performance in 2022

Read about our performance against our strategy and our financial performance below.

Deliver high-value medicines to accelerate growth

Learn more

Embed operational excellence to deliver returns

Learn more

Strengthen our foundations:

Financial performance: Novartis maintained its growth momentum in 2022.

Learn more

Photo Stories

A cancer patient gets a new lease on life

After being diagnosed with advanced prostate cancer, Van Lacour received a Novartis radioligand therapy as part of a managed access program in 2021.

Read the story

Photo Stories

Empowering the next generation of healthcare leaders

Novartis offers paid summer fellowships for students at Historically Black Medical Schools to gain experience in drug discovery, data analytics and clinical research practices - with the goal of training up to 250 scientific leaders over 10 years.

Read the story

Photo Stories

Going upstream to improve heart health in Philadelphia

Cardiovascular disease is the leading cause of death in the US. The Closing the Gap initiative focuses on addressing the upstream social determinants of heart health in five vulnerable neighborhoods in Philadelphia.

Read the story

Photo Stories

In Colombia, a researcher works against a devastating disease

Alexandra Cossio Duque is working to strengthen the capacity of health systems in Colombia to treat leishmaniasis, a neglected tropical disease that is endemic to rural areas.

Read the story

Filter our online integrated report by key topics:

Topic filter